Reply  by Lee, Souki et al.
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Letters to the Editor922mashita et al. (1) showed that pre-reperfusion contrast-enhanced
MDCT is feasible, with a door–to–invasive coronary angiography
time of about 78 min. The door-to-balloon time is not provided by
the investigators in the report but should therefore have been
approximately 90 min, the “target” time set by the most recent
guidelines (2).
As such, this study seems to contradict the guideline that timely
reperfusion be performed in patients with STEMI (2). Yamashita
et al. (1), as well as the editors of iJACC, have decided to open the
ebate over the “time is muscle” paradigm. It is true that it would
e very difficult to show what amount of myocardium would be
rreversibly damaged in the final 20 min of a 4-h to 5-h ischemic
eriod, accounting for the many factors that influence final infarct size
3). In our opinion, it would be of interest to discuss the position of the
nvestigators and editors on this specific question, which is not
iscussed in this report. This question is a sensitive one in the
ardiology community, in which the opinion that a delay in reperfusion
s in conflict with optimal patient care, is shared by many.
The study further opens the door to the important potential of
ardiac MDCT in the acute phase of infarction. Beyond its capacity
o assess coronary perfusion before angioplasty, cardiac MDCT
ould be a very powerful tool to assess the myocardial area at risk.
he accurate assessment of this major determinant of infarct size is
ssential to all therapeutic studies investigating new reperfusion
herapies to increase myocardial salvage and improve patient out-
omes (4). This question is important, because the other clinically
vailable imaging methods to assess the myocardial area at risk
single photon-emission computed tomography, T2-weighted car-
iac magnetic resonance) are not considered definitive standards
nd have well-known limitations. With respect to this issue, it
ould be interesting to know whether Yamashita et al. (1) also
ssessed myocardial perfusion at the tissue level in this cohort of
atients.
Cardiac contrast-enhanced MDCT offers the potential of a
idely available and relatively safe noninvasive imaging method to
ssess STEMI. The current and future applications of the present
ethod must be framed so as to control the absence of adverse
ffects in study patients but offer promising perspectives to better
nderstand and explore STEMI.
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REPLY
We thank Drs. Mewton, Croisille, Bonnefoy-Cudraz, and Ovize
for their valuable comments and suggestions regarding our study
(1,2). They ask whether computed tomography (CT) coronary
angiography performed before emergent percutaneous coronary
intervention (PCI) in patients with ST-segment elevation myo-
cardial infarction (STEMI) inappropriately delayed PCI as per
accepted guidelines (3,4). It is essential to be fully aware of the
specific ethical considerations when reviewing this study. For
example, STEMI patients included in this study were limited to
those with Killip classification 1. Further, CT angiography was
performed in a rapid fashion, at a mean time interval to PCI of
20 min, and CT angiography was completed within the time
required to prepare the catheterization laboratory. Conse-
quently, we believe that the time required to complete the CT
angiography did not appreciably affect patient care. Although we
demonstrated that CT angiography enabled the characterization
of coronary reperfusion during the acute phase in STEMI
patients, we acknowledge that the clinical application of CT
angiography before PCI should be conducted with caution in
patients with STEMI.
As suggested by Mewton et al., CT can be a very powerful tool
to assess the myocardial area at risk in the setting of STEMI. We
regret that we did not assess myocardial perfusion at the tissue level
using CT in our study. Recently, Rodriguez-Granillo et al. (5)
demonstrated that early detection of myocardial viability immedi-
ately after primary PCI, as characterized by delayed enhancement
on multidetector CT, is related to the extent of myocardial damage.
Souki Lee, MD,* Shuichi Hamasaki, MD,
Makoto Yamashita, MD, Chuwa Tei, MD
*Kagoshima City Hospital, Department of Cardiology, 20-17
Kajiyacho, Kagoshima, Kagoshima 892-8580, Japan. E-mail:
lee@ml.kch.kagoshima.kagoshima.jp.
doi:10.1016/j.jcmg.2011.06.011
R E F E R E N C E S
1. Yamashita M, Lee S, Hamasaki S, et al. Noninvasive evaluation of
coronary reperfusion by CT angiography in patients with STEMI. J Am
Coll Cardiol Img 2011;4:141–9.
2. Mewton N, Croisille P, Bonnefoy-Cudraz E, Ovize M. Why delay
intervention in STEMI? J Am Coll Cardiol Img 2011;4:921–2.
p
t
w
t
t
a
w
C
c
H
m
a
b
w
s
J A C C : C A R D I O V A S C U L A R I M A G I N G , V O L . 4 , N O . 8 , 2 0 1 1
A U G U S T 2 0 1 1 : 9 2 1 – 3
Letters to the Editor 9233. Antman EM, Anbe DT, Armstrong PW, et al. ACC/AHA guidelines
for the management of patients with ST-elevation myocardial infarction;
a report of the American College of Cardiology/American Heart Asso-
ciation Task Force on Practice Guidelines (Committee to Revise the
1999 Guidelines for the Management of patients with acute myocardial
infarction). J Am Coll Cardiol 2004;44:E1–211.
4. Kushner FG, Hand M, Smith SC Jr., et al. 2009 focused update:
ACC/AHA guidelines for the management of patients with ST-
elevation myocardial infarction (updating the 2004 guidelines and
2007 focused update). J Am Coll Cardiol 2009;54:2205–41.
5. Rodriguez-Granillo GA, Rosales MA, Baum S, et al. Early assessment of
myocardial viability by the use of delayed enhancement computed
tomography after primary percutaneous coronary intervention. J Am Coll
Cardiol Img 2009;9:1072–81.
Editors’ Response
In their letter regarding the study by Yamashita et al. (1), Mewton
et al. (2) point out that performing a computed tomography scan
immediately before invasive angiography in patients with ST-
segment elevation myocardial infarction may interfere with current
guidelines which mandate to perform primary percutaneous coro-
nary intervention “as quickly as possible, with a goal of . . . within
90 min” (3). Indeed, this issue was discussed intensively, both by
the scientific reviewers, and in the editorial meetings, at various
steps of revision of this paper prior to final acceptance. Various
clarifications added to the paper (such as the exclusion of high riskatients and the overall door-to-catheterization time of 77 min),
he notion that the time interval required for computed tomography
as not completely “lost” but used for catheterization lab prepara-
ion, and the fact that IRB approval was explicitly stated, finally led
o acceptance of the paper for publication. However, in hindsight,
n even more critical appraisal and discussion within the paper
ould probably have been warranted. Studies submitted to JACC:
ardiovascular Imaging have been rejected if interference with
linical guidelines could not be clarified during the review process.
owever, a universally accepted policy does not exist among
edical journals, and scientific publications do not have the means
nd resources to verify the decision process of local IRBs. Contri-
utions such as the letter by Mewton et al. (2) are therefore most
elcome and serve as a vivid example of valuable interaction in the
cientific community.
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